FundedIQ
Biotechnology

FaceFirst: Funding, Investors & Team (Sep 2026)

FaceFirst is a platform that employs facial recognition technology to avoid fraud, security hazards, and potential threats to public safety. The company offers face-matching systems for a variety of industries including retailers, hospitals, casinos, airports, stadiums, and arenas. FaceFirst's software utilizes a combination of artificial intelligence and human monitoring to deter violence, theft, and fraudulent activities.

facefirst.com LinkedIn Austin, United States 51-100 employees
Biometrics Facial Recognition Information Technology Security Software B2B
Total raised
$7.1M
Rounds
2
Latest
Undisclosed round
Mar 2024

FaceFirst has raised $7.1M across 2 funding rounds on record, the most recent an undisclosed round of $5.5M announced in Mar 2024.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

FaceFirst Company Profile and Key Stats

Total funding raised
$7.1M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$5.5M in Mar 2024
Employees
51-100
reported band
Headquarters
Austin, United States

Latest funding round on record: Mar 2024.

FaceFirst Funding Rounds

Date
Round
Amount
Undisclosed round
$5.5M
Undisclosed round
$1.6M

FaceFirst raised $1.6M in an undisclosed round announced in Aug 2022.

1.6 years later, an undisclosed round of $5.5M was announced in Mar 2024.

FaceFirst Founders and Leadership Team

Name
Role
Contact
Kevin Bridges
Founder
Dan Merkle
CEO

No contact details are on record for this team yet.

FaceFirst Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

FaceFirst's latest round of $5.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like FaceFirst in Biotechnology and Austin

Companies Similar to FaceFirst

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

FaceFirst Funding FAQs

What does FaceFirst do?

FaceFirst is a platform that employs facial recognition technology to avoid fraud, security hazards, and potential threats to public safety. The company offers face-matching systems for a variety of industries including retailers, hospitals, casinos, airports, stadiums, and arenas. FaceFirst's software utilizes a combination of artificial intelligence and human monitoring to deter violence, theft, and fraudulent activities.

How much funding has FaceFirst raised?

FaceFirst has raised $7.1M across 2 rounds on record. The most recent is an undisclosed round of $5.5M announced in Mar 2024.

When did FaceFirst last raise funding?

FaceFirst's most recent funding round on record is an undisclosed round of $5.5M, announced in Mar 2024.

Who founded FaceFirst?

FundedIQ lists Kevin Bridges (Founder) at FaceFirst.

Who is the CEO of FaceFirst?

Dan Merkle is listed as CEO at FaceFirst.

Where is FaceFirst headquartered?

FaceFirst is based in Austin, Texas, United States.

How many employees does FaceFirst have?

FaceFirst is in the 51-100 employee band.

How does FaceFirst's funding compare to other Biotechnology startups?

FaceFirst's latest round of $5.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's FaceFirst Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FaceFirst is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.